Law360, New York (June 01, 2004, 12:00 AM ET) -- The Court of Appeals for the Federal Circuit in Washington, D.C. has confirmed that Cordis Corp. is likely to prevail at trial on the merits of claims that its core patent on balloon expandable stents is valid and infringed by Boston Scientific's Taxus Stent.
However, the court affirmed a lower court ruling denying Cordis Corporation a preliminary injunction barring sales of the Boston Scientific’s Taxus stent, citing a lack of irreparable harm from denial of the injunction.
"We are disappointed the Court of Appeals denied the...
Federal Circuit Says Cordis Likely To Prevail In Patent Case Vs. Boston Scientific
To view the full article, take a free trial now.
